Editors Pick
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M
Ahmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Latest
Subscription of Piramal debentures by Canadian investor approved by CCI
The Competition Commission of India (CCI) in a tweet said it “approves the subscription of CCDs of Piramal Enterprises by CDPQ. Upon conversion,...
Merck to acquire cancer drug developer ArQule for USD 2.7 billion
New Delhi: Merck, known as MSD outside the United States and Canada, and ArQule, Inc. recently announced that the companies have entered into a defini...
Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO
Prior to this appointment at Transasia Bio-Medicals, Ravi Kaushik was Group Marketing Director – Asia Pacific & Country Business Director &#...
Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit
Sanofi, which is due to further detail strategic plans to investors on Tuesday in Cambridge, Massachusetts, said it was targeting new cost savings of ...
SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing
The panel voted 11-2 against approving Correvio Pharma’s drug, Brinavess, citing serious safety risks, including low blood pressure and irregula...
Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study
Biohaven Pharmaceutical’s study of its experimental Alzheimer’s treatment, Troriluzole is being led by the Alzheimer’s Disease Coope...
Pharmaceuticals
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M
Ahmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database
CDSCO is preparing a comprehensive database of sites and investigators involved in the conduct of the clinical trial in different therapeutic categori...
Subscription of Piramal debentures by Canadian investor approved by CCI
The Competition Commission of India (CCI) in a tweet said it “approves the subscription of CCDs of Piramal Enterprises by CDPQ. Upon conversion,...
Hospitals & Diagnostics
Genomica, HuaSin Science complete first CLART diagnostic equipment for early diagnosis of cancer in China
New Delhi: GENOMICA, the molecular diagnostics company belonging to the PharmaMar Group begins to materialize its first contract in China with the med...
Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore
The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the se...
Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore
The profit after tax works out to Rs 43 crore in Q2 FY20, up 43.7 per cent from Rs 30 crore in Q2 FY19. Mumbai: Leading diagnostic service provider Me...
IT / Health Venture
3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US
The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of frau...
Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore
The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the se...
Transasia-Erba group unveils TB testing device MX 16
Transasia-Erba group has unveiled the MX 16, a fully automated molecular testing system, at the ongoing 50th Union World Conference on Lung Health and...
Insurance
True North gets IRDAI nod to buy 51 pc stake in Max Bupa at enterprise value of Rs 1 crore
The all-cash transaction announced in February 2019 valued Max Bupa at an enterprise value of Rs 1,001 crore, Max India said in a statement. New Delh...
Insurance coverage for CAR-T cell therapies from Novartis, Gilead get Swiss Govt nod
The health department said the decision covered Novartis’s Kymriah and Gilead’s Yescarta. New Delhi: The Swiss government approved on Frid...
Health Insurance- The Best Backup Plan in Today’s Times
Healthcare delivery sector is advancing at a lightening pace with doctors now capable to threatening many threatening diseases that earlier were thoug...
Implants / Devices
Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO
Prior to this appointment at Transasia Bio-Medicals, Ravi Kaushik was Group Marketing Director – Asia Pacific & Country Business Director &#...
How to make Medical Devices Affordable- Minister apprises Lok Sabha
New Delhi: Through a written reply, the Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently apprised the Parliament abo...
Materiovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug Controllers
New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation (CDSCO) has informed all the State Drug Controllers about it...
Policy
CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database
CDSCO is preparing a comprehensive database of sites and investigators involved in the conduct of the clinical trial in different therapeutic categori...
CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years
The direction to submit PSURs came after various stakeholders of Veterinary products raised a concern regarding the clarification with respect to Phar...
Govt action against BioMed contaminated polio vaccine supply; Minister informs RS
New Delhi: The Minister in the Ministry of Health and Family Welfare, Ashwini Kumar Choubey recently informed the Parliament about the action taken by...
AYUSH
Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut
The objective is to spread the natural healing touch of Unani and reach out to people wanting natural, herbal treatment for lifestyle diseases, and a ...
Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked
Jaipur: Discovering that an Ayurvedic firm was selling Ayurvedic diabetes medicines and Dietary Supplements that actually contained the allopathic for...
Ministry of AYUSH invites initial bids for strategic sale of IMPCL
If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to ...
